Daptomycin for methicillin-resistant and methicillin-sensitive staphylococcus aureus infection a review of clinical effectiveness, cost-effectiveness and guidelines

The aim of this review is to summarize evidence on the comparative clinical and cost effectiveness of daptomycin to other antibiotics for the treatment of bacteremia and other infections caused by methicillin susceptible staphylococcus aureus (MSSA) or methicillin resistant staphylococcus aureus (MR...

Full description

Bibliographic Details
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa (ON) CADTH Rapid Response Service 2016, 2016
Series:Rapid response report: summary with critical appraisal
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The aim of this review is to summarize evidence on the comparative clinical and cost effectiveness of daptomycin to other antibiotics for the treatment of bacteremia and other infections caused by methicillin susceptible staphylococcus aureus (MSSA) or methicillin resistant staphylococcus aureus (MRSA), and to summarize evidence-based guidelines regarding the use of daptomycin for MRSA and MSSA bacteremia or infection
Item Description:"21 January 2016."
Physical Description:1 PDF file (40 pages) illustration